Physician profile
John C Fueston
NPI 1023000692
$1,566.68
in general payments reported to CMS, 2019-2025
19 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $294 · 2021: $214 · 2022: $82.40 · 2023: $359 · 2024: $95.59 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.68 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $390.25 | 2019-2025 | |
| Lilly USA, LLC | $223.53 | 2020-2023 | Taltz |
| Regeneron Healthcare Solutions, INC. | $132.20 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $123.42 | 2023 | Sotyktu |
| Pfizer INC. | $106.45 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $103.35 | 2020-2025 | |
| Janssen Biotech, INC. | $102.56 | 2020-2025 | Tremfya |
| Genzyme Corporation | $68.79 | 2019-2021 | |
| Ucb, INC. | $51.80 | 2021-2024 | Bimzelx |
| Leo Pharma INC. | $51.71 | 2022 | |
| Galderma Laboratories, L.P. | $50.28 | 2019-2020 | |
| Incyte Corporation | $32.52 | 2021-2022 | |
| Epi Health, LLC | $27.57 | 2020-2021 | |
| Dermira, INC. | $24.40 | 2019 | |
| Genentech USA, INC. | $23.24 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $22.67 | 2020 | |
| Dermavant Sciences, INC. | $14.00 | 2023 | Vtama |
| Vyne Pharmaceuticals INC. | $12.71 | 2020 | |
| Organon LLC | $5.23 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fueston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.